Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tert-Butylamine SCHEMBL7125928 | 0.94 | — | — | |
| Tert-Butylamine SCHEMBL6330044 | 0.94 | — | — | |
| Tert-Butylamine SCHEMBL8051 | 0.93 | — | — | |
| Tert-Butylamine SCHEMBL5736553 | 0.93 | — | — | |
| Tert-Butylamine SCHEMBL6064515 | 0.93 | FDPS (0.33) | — | |
| Tert-Butylamine SCHEMBL184405 | 0.86 | — | — | |
| Tert-Butylamine SCHEMBL263850 | 0.86 | — | — | |
| Tert-Butylamine SCHEMBL7781705 | 0.86 | — | — | |
| Tert-Butylamine SCHEMBL189940 | 0.86 | — | — | |
| Tert-Butylamine SCHEMBL20597076 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4628492-A1 | PREPARATION METHOD FOR LINKER-DRUG CONJUGATE AND INTERMEDIATE THEREOF | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| CN-115385926-B | Preparation method of linker drug conjugate and intermediate thereof | 上海复旦张江生物医药股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2024140934-A1 | PREPARATION METHOD FOR LINKER-DRUG CONJUGATE AND INTERMEDIATE THEREOF | 上海复旦张江生物医药股份有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-116836215-A | Synthesis method of natural product Sokotrasterol sulfate | 中国药科大学 | 2023-10-03 | — | — | CN | claimed |
| CN-116217655-A | Preparation method of intermediate of linker drug conjugate | 上海复旦张江生物医药股份有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-116178386-A | Preparation method of linker drug conjugate and intermediate thereof | 上海复旦张江生物医药股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-110272462-B | Process for preparing compounds | 南开大学 | 2023-03-10 | — | — | CN | claimed |
| CN-115385926-A | Preparation method of connection base drug conjugate and intermediate thereof | 上海复旦张江生物医药股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115215921-A | Preparation method of connection base drug conjugate and intermediate thereof | 上海复旦张江生物医药股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| WO-2020035782-A1 | MOLECULAR PROBES FOR ANALYSIS OF METABOLISM OF GLYCOLYSIS INHIBITORS PRODRUGS AND SYNTHESIS METHODS THEREFORE | DERMIN SP. Z O.O. (PL) | 2020-02-20 | — | — | WO | claimed |
| EP-1737877-B1 | PROCESS FOR THE REMOVAL OF EXOCYCLIC BASE PROTECTING GROUPS | AVECIA BIOTECHNOLOGY INC (US) | 2008-07-09 | — | — | EP | claimed |
| WO-2008065522-A2 | PROCESS FOR THE SYNTHESIS OF 4-DIFLUOROMETHOXY-8-NITRO-1-FORMYL DIBENZO[B,D] FURAN-AN INTERMEDIATE FOR PDE IV INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-06-05 | — | — | WO | claimed |
| WO-2008007127-A1 | FURO [3,2-B] PYRROL-3-ONE DERIVATIVES AND THEIR USE AS CYSTEINYL PROTEINASE INHIBITORS | AMURA THERAPEUTICS LIMITED (GB) | 2008-01-17 | — | — | WO | claimed |
| US-7166539-B2 | Wet etching method of removing silicon from a substrate | MICRON TECHNOLOGY, INC. (US) | 2007-01-23 | — | — | US | claimed |
| US-7135381-B2 | Wet etching method of removing silicon from a substrate and method of forming trench isolation | MICRON TECHNOLOGY, INC. (US) | 2006-11-14 | — | — | US | claimed |
| US-20060252794-A1 | Process for preparing 5-'(r)-2-(5,6-diethyl-indian-2-ylamino)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an andrenoceptor agonist | NOVARTIS AG (CH) | 2006-11-09 | — | — | US | claimed |
| US-20060024914-A1 | Wet etching method of removing silicon from a substrate and method of forming trench isolation | MICRON SEMICONDUCTOR PRODUCTS, INC. | 2006-02-02 | — | — | US | claimed |
| US-20050020091-A1 | Wet etching method of removing silicon from a substrate and method of forming trench isolation | MICRON TECHNOLOGY, INC. | 2005-01-27 | — | — | US | claimed |
| US-5167783-A | Capillary gel electrophoresis columns and method of preparing the same | HEWLETT-PACKARD COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| EP-0232997-B1 | ANTIHYPERCHOLESTEROLEMIC COMPOUNDS | MERCK & CO. INC. (US) | 1990-09-19 | — | — | EP | claimed |